The autoimmune target for CD is the villi lining the intestinal tract, which is predominantly made of tissue transglutaminase-2 (tTG2).
Celiac patients are more sensitive to the deamidated gliadin (gluten) than to non-deamidated gliadin, thus deamidated gliadin peptide (DGP) is the preferred biomarker for identifying possible CD.
Early detection and adherence to the gluten-free diet are vital, as patients with CD have greater incidences of co-autoimmune disorders, risk for cancer and elevated mortality rates.
A positive celiac result will come with a complimentary Gluten Free Diet, which lists common gluten-containing foods, sample meal options, reading food labels, and more.
Tissue Transglutaminase (tTG) IgA
Tissue Transglutaminase (tTG) IgG
Deamidated Gliadin Peptide (DGP) IgA
Deamidated Gliadin Peptide (DGP) IgG
Serum: 1 mL
